Abstract:Nlp (ninein-like protein), an important molecule involved in centrosome maturation and spindle formation, plays an important role in tumorigenesis and its abnormal expression was recently observed in human breast and lung cancers. In this study, the correlation between overexpression of Nlp and paclitaxel chemosensitivity was investigated to explore the mechanisms of resistance to paclitaxel and to understand the effect of Nlp upon apoptosis induced by chemotherapeutic agents. Nlp expression vector was stably transfected into breast cancer MCF-7 cells. With Nlp overexpression, the survival rates, cell cycle distributions and apoptosis were analyzed in transfected MCF-7 cells by MTT test and FCM approach. The immunofluorescent assay was employed to detect the changes of microtubule after paclitaxel treatment. Immunoblotting analysis was used to examine expression of centrosomal proteins and apoptosis associated proteins. Subsequently, Nlp expression was retrospectively examined with 55 breast cancer samples derived from paclitaxel treated patients. Interestingly, the survival rates of MCF-7 cells with Nlp overexpressing were higher than that of control after paclitaxel treatment. Nlp overexpression promoted G(2)-M arrest and attenuated apoptosis induced by paclitaxel, which was coupled with elevated Bcl-2 protein. Nlp expression significantly lessened the microtubule polymerization and bundling elicited by paclitaxel attributing to alteration on the structure or dynamics of beta-tubulin but not on its expression. The breast cancer patients with high expression of Nlp were likely resistant to the treatment of paclitaxel, as the response rate in Nlp negative patients was 62.5%, whereas was 58.3 and 15.8% in Nlp (+) and Nlp (++) patients respectively (p = 0.015). Nlp expression was positively correlated with those of Plk1 and PCNA. These findings provide insights into more rational chemotherapeutic regimens in clinical practice, and more effective approaches might be developed through targeting Nlp to increase chemotherapeutic sensitivity.

Inhibition Of Notch1 Increases Paclitaxel Sensitivity To Human Breast Cancer

Targeted Inhibition of Notch1 Gene Enhances the Killing Effects of Paclitaxel on Triple Negative Breast Cancer Cells.

Inhibition of the notch signaling pathway overcomes resistance of cervical cancer cells to paclitaxel through retardation of the epithelial–mesenchymal transition process

Knockdown of nuclear receptor binding SET domain-containing protein 1 (NSD1) inhibits proliferation and facilitates apoptosis in paclitaxel-resistant breast cancer cells via inactivating the Wnt/β-catenin signaling pathway

The Role of CYP1B1 in Paclitaxel Resistance in Breast Cancer

Notch-1 Confers Chemoresistance in Lung Adenocarcinoma to Taxanes Through AP-1/microRNA-451 Mediated Regulation of MDR-1

Rnai-Mediated Knockdown Of Notch-1 Leads To Cell Growth Inhibition And Enhanced Chemosensitivity In Human Breast Cancer

Proteomic analysis of the proteins that are associated with the resistance to paclitaxel in human breast cancer cells.

Silencing Dishevelled‐1 Sensitizes Paclitaxel‐resistant Human Ovarian Cancer Cells Via AKT/GSK‐3β/β‐catenin Signalling

Silencing of PGK1 Promotes Sensitivity to Paclitaxel Treatment by Upregulating XAF1-Mediated Apoptosis in Triple-Negative Breast Cancer

Downregulated Mucin 1 alleviates paclitaxel resistance in non‐small cell lung cancer cells

Role of Tumor Necrosis Factor Alpha-Induced Protein 1 in Paclitaxel Resistance.

Inhibition of Notch pathway Alleviates nab-Paclitaxel-Induced Peripheral Neuropathic Pain in Rats via Suppressing HMGB1/TLR4 Signaling in Spinal Cord

End-binding protein 1 stimulates paclitaxel sensitivity in breast cancer by promoting its actions toward microtubule assembly and stability

Targeting DKK1 enhances the antitumor activity of paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer

Silencing Notch-1 Induces Apoptosis and Increases the Chemosensitivity of Prostate Cancer Cells to Docetaxel Through Bcl-2 and Bax

Effect of Notch-1 Small Interfering RNA on Biological Function of Triple-Negative Breast Cancer Cell Line MDA-MB-231

High Expression of Timp-1 in Human Breast Cancer Tissues is A Predictive of Resistance to Paclitaxel-Based Chemotherapy

The telomere/telomerase binding factor PinX1 regulates paclitaxel sensitivity depending on spindle assembly checkpoint in human cervical squamous cell carcinomas.

Overexpression of Centrosomal Protein Nlp Confers Breast Carcinoma Resistance to Paclitaxel

Silencing MAP3K1 Expression Through RNA Interference Enhances Paclitaxel-Induced Cell Cycle Arrest in Human Breast Cancer Cells